Concepedia

Andrea Kohánka

AK

Statistics

Publications

2

Citations

72

H-Index

2

Active since

2013

Affiliations

Semmelweis University(Current)

Andrea Kohánka is an author at Semmelweis University specializing in neoplasia, met-targeted therapy, and oncology.

ORCID

Publications per year

2013–2022

2

Publications

2

Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement

Richárd Schwab, István Peták, Mihaly Kollar et al. · Lung Cancer · 2013 · 60 citations

, , +17

EGFR T790M Mutation Detection in Patients With Non-Small Cell Lung Cancer After First Line EGFR TKI Therapy: Summary of Results in a Three-Year Period and a Comparison of Commercially Available Detection Kits

Eszter Bencze, Krisztina Bogos, Andrea Kohánka et al. · Pathology & Oncology Research · 2022 · 12 citations · Full text

, , +16

1–2 of 2